Drug intelligence / Profile preview

Clioquinol

Development stage
Phase 2
Lead developer
Novartis
Modality
Small Molecules
Administration
Topical, Oral
01

Overview

Clioquinol is a synthetic small molecule belonging to the hydroxyquinoline class. It is primarily used as a topical antifungal and antibacterial agent for treating skin infections such as eczema, athlete's foot, jock itch, and ringworm[2][4][5]. Clioquinol acts as a broad-spectrum anti-infective with both antifungal and antiprotozoal properties[3][5]. Its mechanism of action includes chelation of zinc and copper ions—an activity that disrupts metal-dependent enzymes in pathogens—and possible inhibition of kappa-type opioid receptors[3][6][8]. Clioquinol has also been investigated for its potential in neurodegenerative diseases (such as Alzheimer's disease and Parkinson's disease) due to its ability to chelate metals implicated in amyloid plaque formation[6][8], and it has shown anticancer effects in preclinical prostate cancer models by acting as a zinc ionophore[5]. The drug was withdrawn from some markets due to concerns about neurotoxicity at high doses or prolonged use but remains available topically in certain regions.

Brand names
Entero-VioformVioformLocacorten VioformDermasorb AF Complete Kit
Other names
iodochlorhydroxyquin5-chloro-7-iodo-8-hydroxyquinoline
02

Targets

KOR (Kappa opioid receptor)ACE2 (Angiotensin-converting enzyme 2)

Beyond the preview

Go deeper on Clioquinol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Clioquinol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call